England - London • Industry focus
Mishcon de Reya LLP
Noted by clients for its ‘great pedigree’, the team at Mishcon de Reya LLP has broad knowledge spanning digital health, crop science, and veterinary medicine. Joining the practice with his team through the firm’s merger with Taylor Vinters, Patrick Farrant co-heads the practice alongside Campbell Forsyth. Farrant has deep expertise in the negotiation of biotech IP deals and licences, while Forsyth handles a broad range of patent disputes before the High Court. Hailed by clients as a ‘statesman at the top of his game’, David Rose is particularly apt at advising on the protection and enforcement of IP rights, FRAND terms, and the protection of SPCs. Praised for his ‘blue sky thinking’, counsel Justin Lambert has vast expertise in matters concerning the freedom to operate, and often acts in infringement disputes.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Depth and breadth of thought is key to the Mishcon de Reya team. They make use of knowledge and experience at all levels, and their advice and work is much richer and more robust as a result. They know their cases inside out.’
‘Justin Lambert is an experienced litigator. He is easy to work with and is excellent at blue sky thinking. He will come up with ideas that no-one else has considered. He has a good science background.’
‘A solid team with a great pedigree!’
‘David Rose continues to impress, he is a statesman at the top of his game.’
‘James Holland is an increasingly confident and competent senior associate. He takes on the management of larger litigation teams, with excellent results as his knowledge develops in sync and his advice becomes sharper.’
Key clients
- Dr Reddy Laboratories
- Zentiva
- United Bioscience Corp
- Lupin
- Nucleome Therapeutics
- RQ Bio
- DIOSynVax
- RxCelerate
- Endomag
- RSC
- Quell Therapeutics
- Purespring
- Mestag Therapeutics
- Microbiotica
- Centauri Therapeutics
- Sanofi
Work highlights
- Acting for Dr Reddy's Laboratories (UK) Limited in a follow-on cross-undertaking damages claim against Warner-Lambert in relation to its invalid pregabalin second medical use patent.
- Acting separately for Zentiva Pharma UK Limited and Dr Reddy's Laboratories (UK) Limited in a multi-party pharmaceutical dispute regarding a patent for a dosage regimen relating to fingolimod.
- Advising RQ Bio on its $157m licence with AstraZeneca to help progress the treatment and prevention of viruses through antibody technologies.
Practice head
The lawyer(s) leading their teams.
Patrick Farrant, Campbell Forsyth